Conference paper
The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)
J Gardašanić
M Štefanić
I Mihaljević
B Krstonošić
Full text: croatian pdf 497 Kb
page 114-114
downloads: 390
cite
APA 6th Edition
Gardašanić, J., Štefanić, M., Mihaljević, I. & Krstonošić, B. (2007). The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica, 46 (3-Supplement 2), 114-114. Retrieved from https://hrcak.srce.hr/17577
MLA 8th Edition
Gardašanić, J, et al. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica, vol. 46, no. 3-Supplement 2, 2007, pp. 114-114. https://hrcak.srce.hr/17577. Accessed 2 May 2024.
Chicago 17th Edition
Gardašanić, J, M Štefanić, I Mihaljević and B Krstonošić. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica 46, no. 3-Supplement 2 (2007): 114-114. https://hrcak.srce.hr/17577
Harvard
Gardašanić, J., et al. (2007). 'The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)', Acta clinica Croatica, 46(3-Supplement 2), pp. 114-114. Available at: https://hrcak.srce.hr/17577 (Accessed 02 May 2024)
Vancouver
Gardašanić J, Štefanić M, Mihaljević I, Krstonošić B. The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica [Internet]. 2007 [cited 2024 May 02];46(3-Supplement 2):114-114. Available from: https://hrcak.srce.hr/17577
IEEE
J. Gardašanić, M. Štefanić, I. Mihaljević and B. Krstonošić, "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)", Acta clinica Croatica, vol.46, no. 3-Supplement 2, pp. 114-114, 2007. [Online]. Available: https://hrcak.srce.hr/17577. [Accessed: 02 May 2024]
Full text: english pdf 497 Kb
page 114-114
downloads: 291
cite
APA 6th Edition
Gardašanić, J., Štefanić, M., Mihaljević, I. & Krstonošić, B. (2007). The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica, 46 (3-Supplement 2), 114-114. Retrieved from https://hrcak.srce.hr/17577
MLA 8th Edition
Gardašanić, J, et al. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica, vol. 46, no. 3-Supplement 2, 2007, pp. 114-114. https://hrcak.srce.hr/17577. Accessed 2 May 2024.
Chicago 17th Edition
Gardašanić, J, M Štefanić, I Mihaljević and B Krstonošić. "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)." Acta clinica Croatica 46, no. 3-Supplement 2 (2007): 114-114. https://hrcak.srce.hr/17577
Harvard
Gardašanić, J., et al. (2007). 'The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)', Acta clinica Croatica, 46(3-Supplement 2), pp. 114-114. Available at: https://hrcak.srce.hr/17577 (Accessed 02 May 2024)
Vancouver
Gardašanić J, Štefanić M, Mihaljević I, Krstonošić B. The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC). Acta clinica Croatica [Internet]. 2007 [cited 2024 May 02];46(3-Supplement 2):114-114. Available from: https://hrcak.srce.hr/17577
IEEE
J. Gardašanić, M. Štefanić, I. Mihaljević and B. Krstonošić, "The Role of 18-FDG-PET in Post-¬treatment Restaging of Recurrent Differentiated/Medullary Thyroid Carcinoma (DTC/MTC)", Acta clinica Croatica, vol.46, no. 3-Supplement 2, pp. 114-114, 2007. [Online]. Available: https://hrcak.srce.hr/17577. [Accessed: 02 May 2024]
Abstract
Keywords
Hrčak ID:
17577
URI
https://hrcak.srce.hr/17577
Publication date:
1.10.2007.
Article data in other languages:
croatian
Visits: 1.355
*
